Filana Therapeutics
FLNA
51 hedge funds and large institutions have $18.5M invested in Filana Therapeutics in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 12 closing their positions.
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
105% more call options, than puts
Call options by funds: $1.78M | Put options by funds: $867K
92% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 12
28% more funds holding
Funds holding: 40 → 51 (+11)
0.1% less ownership
Funds ownership: 24.29% → 24.19% (-0.1%)
25% less capital invested
Capital invested by funds: $24.8M → $18.5M (-$6.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.36M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.06M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.04M |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$962K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
-$3.13M |
| 2 |
Renaissance Technologies
New York
|
-$2.69M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.53M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.32M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.23M |
FLNA Hedge Fund Activity: Q2 2020 in Review
51 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2020, worth a combined $18.5M — down 25% from $24.8M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new FLNA positions and 12 closed out — a net gain of 11 holders — while 17 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $5.36M. The largest seller was Bleichroeder LP, cutting an estimated $3.13M.
- 51 institutional investors held Filana Therapeutics (FLNA) as of Q2 2020, up from 40 in Q1 2020.
- Funds reported $18.5M of Filana Therapeutics stock for Q2 2020, down 25% quarter-over-quarter.
- 23 funds opened new Filana Therapeutics positions in Q2 2020 and 12 closed out, a net change of +11 holders.
- The largest Filana Therapeutics buyer in Q2 2020 was BlackRock, an estimated $5.36M added.
- The largest Filana Therapeutics seller in Q2 2020 was Bleichroeder LP, an estimated $3.13M sold.
Based on aggregated 13F filings for Q2 2020.